Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Centers for Disease Control and Prevention
International shipping is available
Fresh solutions should be prepared for each experiment, as stock solutions degrade over repeated handling and freeze-thaw cycling
You should get B12 shots weekly to monthly for maintenance and IV infusions monthly to quarterly for broader wellness support, though frequency depends on deficiency severity, health goals, and your providers recommendation
US$ 22.68
US$ 29.04
US$ 20.33
US$ 26.22
US$ 28.95
US$ 24.25
